PHILADELPHIA, PA., May 24, 2016 -- The Center for Information and Study on Clinical Research Participation (CISCRP), an independent non-profit organization, is excited to announce its upcoming Medical Heroes Appreciation 5K Fun Run & Walk in Philadelphia, PA to honor the volunteers who give the gift of participation in clinical research and to raise awareness about the importance of clinical research in advancing public health.
The event will take place on Monday, June 27, 2016 from 6:30-8:15am, in conjunction with the DIA 2016 meeting. The start/finish location is at 1 Boathouse Row. Participants are encouraged to register early as space is limited. To register, visit ciscrp.org/medhero5k-philadelphia. On behalf of every 5K registrant, the Greater Gift Initiative will also donate one vaccine to a child in need.
"Through their participation in clinical trials each year, millions of people are Medical Heroes, helping to advance public health and knowledge about disease and new treatments," said CISCRP's Founder and Board Chair Ken Getz. "With this special event, we continue to recognize their gift of participation, raise public awareness, and express our gratitude and admiration."
Event sponsors and supporters see the 5K as a unique opportunity to celebrate clinical study volunteers for their participation. "We're proud to partner with CISCRP on many of its public and patient serving initiatives including the Medical Heroes Appreciation 5K, which gives us the opportunity to put our best foot forward in recognizing and expressing gratitude for clinical trial volunteers," said Paulo Moreira, VP - GCO, Head of External Innovation at EMD Serono, which has served as a Champion supporter for each Medical Heroes Appreciation 5K since the initiative's 2014 inception.
Early check-in will be hosted throughout the day at the DIA 2016 registration area in the Pennsylvania Convention Center on Sunday, June 26. Check-in on the day of the event begins at 6am, and the 5K will begin at 6:30am. For more information about the event, to volunteer, register or become a sponsor, visit ciscrp.org/medhero5k-philadelphia or call toll free 1-877-MED-HERO (1-877-633-4376). Questions about sponsorship opportunities can go directly to [email protected].
About CISCRP
CISCRP is a 501(c)(3) non-profit organization dedicated to engaging the public and patients as partners in the clinical research process. CISCRP provides free education and outreach to the general public and patient communities. Visit www.CISCRP.org for more information or to support CISCRP.
|
|||||
A photo accompanying this release is available at:
http://www.globenewswire.com/newsroom/prs/?pkgid=40340
CONTACT: Danielle Lavieri
Marketing and Communications Manager
617-725-2750
[email protected]


Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Washington Post Publisher Will Lewis Steps Down After Layoffs
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 



